Stockscreener 앱 받기
6.98
5.03%
-0.37
시간 외 거래:
6.76
-0.22
-3.15%
전일 마감가:
$7.35
열려 있는:
$7.23
하루 거래량:
21,430
Relative Volume:
1.04
시가총액:
$6.43M
수익:
$4.03M
순이익/손실:
$24.32M
주가수익비율:
-1.623
EPS:
-4.3008
순현금흐름:
$-45.76M
1주 성능:
-1.41%
1개월 성능:
-29.28%
6개월 성능:
-61.03%
1년 성능:
-63.83%
1일 변동 폭
$6.97
$8.1163
1주일 범위
$6.00
$9.255
52주 변동 폭
$6.00
$26.85
Pavmed Inc Stock (PAVM) Company Profile
명칭
Pavmed Inc
전화
(212) 949-4319
주소
360 MADISON AVENUE, NEW YORK, NY
PAVM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PAVM
Pavmed Inc
|
6.98 | 6.77M | 4.03M | 24.32M | -45.76M | -4.3008 |
|
ABT
Abbott Laboratories
|
127.78 | 219.88B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
97.79 | 141.54B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
366.39 | 133.39B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.31 | 124.82B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.85 | 48.84B | 5.88B | 1.34B | 799.60M | 2.3489 |
Pavmed Inc Stock (PAVM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-03-30 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-11-05 | 개시 | Ascendiant Capital Markets | Buy |
| 2018-06-28 | 개시 | Maxim Group | Buy |
Pavmed Inc 주식(PAVM)의 최신 뉴스
PAVmed Announces Reverse Stock Split - citybiz
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 14, 2025 - marketscreener.com
PAVMED announces 1-for-30 reverse stock split - MSN
PAVmed trading halted, news pending - MSN
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
PAVmed stock drops after announcing 1-for-30 reverse split By Investing.com - Investing.com Canada
PAVmed (PAVM) Announces 1-for-30 Reverse Stock Split - GuruFocus
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
PAVmed to implement 1-for-30 reverse stock split in January - Investing.com Nigeria
PAVmed stock drops after announcing 1-for-30 reverse split - Investing.com India
PAVmed to implement 1-for-30 reverse stock split in January By Investing.com - Investing.com South Africa
PAVmed Announces Reverse Stock Split to Maintain Nasdaq Listing - TipRanks
PAVmed announces reverse stock split - marketscreener.com
PAVmed announces reverse stock split to maintain Nasdaq listing - MSN
PAVmed Inc. (NASDAQ:PAVM) Sees Large Drop in Short Interest - Defense World
Here's Why Lucid Diagnostics (LUCD) Declined in Q3 - Finviz
Is PAVmed Inc. stock a buy on dips2025 Technical Overview & Free Fast Gain Swing Trade Alerts - Улправда
Nasdaq Moves: Will PAVmed Inc. stock gain from strong economyEarnings Trend Report & Reliable Price Breakout Alerts - Улправда
Will PAVmed Inc. stock gain from strong economy2025 Price Momentum & Free Low Drawdown Momentum Trade Ideas - Улправда
PAVM FinancialsIncome Statement - Quiver Quantitative
Ascendiant Capital Maintains PAVmed (PAVM) Buy Recommendation - Nasdaq
Ascendiant Capital Lowers Price Target for PAVmed (PAVM) to $17. - GuruFocus
PAVmed stock price target lowered to $17 from $20 at Ascendiant Capital By Investing.com - Investing.com South Africa
PAVmed stock price target lowered to $17 from $20 at Ascendiant Capital - Investing.com
Lucid Diagnostics reports real-world data on esophageal test device By Investing.com - Investing.com Australia
Lucid Diagnostics reports real-world data on esophageal test device - Investing.com
Lucid Diagnostics Announces Positive Data from the Largest Reported Real-World Experience of Esophageal Precancer Detection - PR Newswire
PAVmed approves reverse stock split amendment - MSN
PAVmed Approves Reverse Stock Split Amendment - The Globe and Mail
Lucid Diagnostics Announces $15.3 Million Registered Direct Offe - GuruFocus
Can PAVmed Inc. stock rebound after recent weaknessMarket Growth Report & Daily Market Momentum Tracking - Newser
Is PAVmed Inc. stock cheap compared to fundamentals2025 Short Interest & Capital Efficiency Focused Ideas - Newser
PAVmed (PAVM) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
What drives PAVmed Inc stock priceInflation Impact on Stocks & Control Your Emotions With Discipline Tools - earlytimes.in
Lucid Diagnostics Inc.'s (NASDAQ:LUCD) largest shareholders are individual investors with 38% ownership, public companies own 30% - Yahoo Finance Singapore
Risk Check: Will PAVmed Inc. stock gain from strong economyRecession Risk & Advanced Swing Trade Entry Plans - BỘ NỘI VỤ
Why Being Public Gave PavMed a Competitive Edge - Medical Device and Diagnostic industry
What analysts say about PAVmed Inc stockPrice Channel Trading & Small Investment Capital Tips - earlytimes.in
Pavmed Inc. Reports Q3 2025 Earnings and Strategic Focus - MSN
Will PAVmed Inc. stock benefit from upcoming earnings reports2025 Retail Activity & Low Drawdown Investment Strategies - newser.com
Lucid Diagnostics Named a GenomeWeb 2025 Best Places to Work Top-Ranking Honoree - PR Newswire
Will PAVmed Inc. stock deliver strong dividend growthStop Loss & Weekly Top Stock Performers List - newser.com
Is PAVmed Inc. stock ready for breakoutPortfolio Gains Report & Community Driven Trade Alerts - newser.com
Is PAVmed Inc. stock cheap at current valuationJuly 2025 Gainers & Consistent Growth Equity Picks - newser.com
Combining machine learning predictions for PAVmed Inc.July 2025 Analyst Calls & Daily Technical Stock Forecast Reports - newser.com
Pavmed Inc (PAVM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.82%
자본화:
|
볼륨(24시간):